Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 760212-58-6 | MDL No. : | MFCD09746342 |
Formula : | C19H13BrN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PPYIZNYOMNYZCG-UHFFFAOYSA-N |
M.W : | 349.22 | Pubchem ID : | 23094071 |
Synonyms : |
|
Num. heavy atoms : | 22 |
Num. arom. heavy atoms : | 21 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 94.21 |
TPSA : | 17.82 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -4.56 cm/s |
Log Po/w (iLOGP) : | 3.35 |
Log Po/w (XLOGP3) : | 5.45 |
Log Po/w (WLOGP) : | 5.46 |
Log Po/w (MLOGP) : | 4.95 |
Log Po/w (SILICOS-IT) : | 4.7 |
Consensus Log Po/w : | 4.78 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -6.01 |
Solubility : | 0.000339 mg/ml ; 0.00000097 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -5.58 |
Solubility : | 0.000917 mg/ml ; 0.00000262 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -7.93 |
Solubility : | 0.00000408 mg/ml ; 0.0000000117 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.29 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | With toluene-4-sulfonic acid In 5,5-dimethyl-1,3-cyclohexadiene at 150℃; for 12 h; | Fourth Step: Synthesis of Intermediate Product (D) (0133) 29.7 g (80.9 mmol) of the intermediate product (C) and 1.4 g (8.1 mmol) of p-toluenesulfonic acid were suspended in 300 mL of xylene and agitated at 150° C. for 12 hours. After cooling, xylene was removed under the reduced pressure to provide a solid, and the solid was recrystallized with methanol to provide 22.4 g (yield: 79percent) of the intermediate product (D). |
52% | With toluene-4-sulfonic acid In xylene for 3 h; Heating / reflux | 2.1 g (5.7 mmol) of N-[2-(4-bromophenylamino)phenyl] benzamide were suspended into 30 mL of xylene, 0.6 g (2.9 mmol) of p-toluenesulfonic acid monohydrate was added, and the whole was refluxed under heating for 3 hours. After the resultant had been stood to cool, the reaction solution was added with ethyl acetate, dichloromethane, and water for filtering insoluble matter out. An organic layer was extracted from a mother liquor, washed with water and a saturated sodium chloride solution, and dried with anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by means of silica gel column chromatography to obtain 1.0 g of 1-(4-bromophenyl)-2-phenyl-1H-benzimidazole (52percent yield). |
52% | With toluene-4-sulfonic acid In xylene for 3 h; Heating / reflux | (3) Synthesis of 1-(4-bromophenyl)-2-phenyl-1H-benzimidazole Suspending 2.1 g (5.7 mmol) of N-[2-(4-bromophenylamino)phenyl] benzamide obtained in the above step (2) into 30 milliliter of xylene, and adding 0.6 g (2.9 mmol) of p-toluenesulfonic acid 1 hydrate, the resultant solution was azeotropically dehydrated while refluxing with heating for 3 hours. After naturally cooling the reacted solution, ethyl acetate, dichloromethane and water were added to the reacted solution, followed by separating an insoluble substance by filtration. Extracting an organic layer from mother liquor, the organic layer was washed with water and a saturated solution of sodium chloride and then, dried with anhydrous sodium sulfate, followed by removing the solvent by distillation under reduced pressure. Refining the residue with silicagel column chromatography, 1.0 g of 1-(4-bromophenyl)-2-phenyl-1H-benzimidazole was obtained as white crystals with a slight pink color (yield: 52 percent). |
52% | for 3 h; Reflux | (C-3) Synthesis of 1-(4-bromophenyl)-2-phenyl-1H-benzimidazole 2.1g (5.7 mmol) of N-[2-(4-bromophenylamino)phenyl]benzamide was suspended in 30 mL of xylene. To the resulting suspension, 0.6g (2.9 mmol) of p-toluenesulfonic acid monohydrate was added, and the resultant was subjected to azeotropic dehydration while heating under reflux for 3 hours. After allowing it to be cool, ethyl acetate, methylene chloride and water were added to the reaction solution, and unsoluble matters were filtered off. An organic phase was extracted from a mother solution, washed with water and saturated saline, and dried with anhydrous sodium sulfate. The solvent was distilled off under a reduced pressure. Residues were purified by silica gel column chromatography, whereby 1.0g of slightly pinky white crystals of 1-(4-bromophenyl)-2-phenyl-1H-benzimidazole were obtained (yield 52percent). |
30 g | at 250℃; for 3 h; | As shown in synthetic route 4 below, 30 g of intermediate compound M5 was synthesized by a method described in a non-patent document: Chemistry of Materials, 2009, 21(12), 2452. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55.9% | Stage #1: at 20 - 60℃; for 4 h; Stage #2: at 130 - 250℃; for 3 h; Inert atmosphere |
Synthesis of Intermediate 5-C: To a 500ml three-necked round flask with magnetic stirrer was sequentially added with Intermediate 5-B (15.8g, 0.06mol), benzoyl chloride (11.2g, 0.08mol), N-methylpyrrolidone 200ml. After the reaction was stirred at room temperature for 2h, it is continued to warm to 50-60C and was stirred for 2h. After the reaction solution was poured into 200ml of water, the precipitated solid was filtered. After drying under an argon atmosphere and heated to 130C, water is generated, and the reaction at 250C for 3 hours. Cooled to room temperature, extracted with CH2Cl2 to obtain a crude product. The crude product was purified by column chromatography on silica gel, ethyl acetate / petroleum ether as eluent to give 11.7g pale yellow solid, yield 55.9percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43% | for 12 h; Inert atmosphere; Schlenk technique; Reflux | A mixture of benzaldehyde (2.02 g, 19.0 mmol) and N-phenylbenzene-1,2-diamine (1.0 g, 5.43 mmol) was dissolved in 2-methoxyethanol (10 mL). Then the mixture was heat to reflux for 12 h. The solvent was removed and the residue was extracted with dichloromethane (30 mL x 3). The organic layer was washed with water, brine and then dried with anhydrous MgSO4, filtered. After filtration, the filtrate was pumped dry in vacuo. The crude residue was subjected to silica gel column chromatography by eluting with hexanes: dichloromethane (1:1) as an eluting to give a brown solid (yield: 43percent).1H NMR (400 MHz, acetone-d6,):δ (ppm) 7.88 (d, J = 8.8 Hz, 3 H), 7.62-7.60 (m, 2 H), 7.42-7.38 (m, 5H), and 7.38-7.25 (m, 3 H); Mass (FAB): m/z: 351.0 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76.8% | With n-butyllithium In tetrahydrofuran at -78℃; | Synthesis of Intermediate 5-D: In a 250ml three-necked round flask, added was Intermediate 5-C(11.5g, 0.03mol), and 120ml dried THF that underwent treatment with Na /Benzophenone. Liquid nitrogen was used to cool reaction to -78C. While stirring, slowly added dropwise 14.5ml of n-butyllithium (0.036mol, 2.5mol·L-1), and Triisopropyl borate 9.96ml (8.12g, 0.043mol). After the addition was completed, stirred to room temperature. Adding an appropriate amount of dilute hydrochloric acid, hydrolysis, extraction with ethyl acetate, the combined organic phases. The organic solvent was removed by rotary evaporation to give the crude product. After recrystallization from ethanol to give a white solid 7.23g, yield 76.8percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1 h; Stage #2: With Trimethyl borate In tetrahydrofuran; hexane at -78 - 20℃; for 3 h; Stage #3: With hydrogenchloride In tetrahydrofuran; hexane; water for 1 h; |
In an argon atmosphere, 10 g (29 mmol) of 1-(4-bromophenyl)-phenyl-1H-benzimidazole were dissolved into 100 mL of dehydrated THF, and the temperature of the solution was cooled to -78° C. Then, 20 mL of n-butyllithium (in hexane, 1.6 mol/L) were dropped. After the mixture had been stirred at -78° C for 1 hour, the temperature of the mixture was increased to 0°C. The temperature of the mixture was cooled to -78° C again, and 9.7 mL (87 mmol) of trimethoxyborane were dropped. The mixture was stirred at -78° C for 1 hour, and was then stirred at room temperature for 2 hours. 100 mL of 10-mass percent hydrochloric acid were added, and the whole was stirred for 1 hour, followed by filtration. The organic layer of the filtrate was washed with a saturated sodium chloride solution and dried with magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by means of silica gel column chromatography to obtain 4.2 g of 4-(2-phenyl-1H-benzimidazol-1-yl)phenylboronic acid (46percent yield). |
[ 2622-63-1 ]
1-Methyl-2-phenyl-1H-benzo[d]imidazole
Similarity: 0.87
[ 2963-77-1 ]
4-(1H-Benzo[d]imidazol-2-yl)aniline
Similarity: 0.83
[ 169205-78-1 ]
N4-(3-Bromophenyl)quinazoline-4,6-diamine
Similarity: 0.82
[ 13676-49-8 ]
2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine
Similarity: 0.81
[ 169205-78-1 ]
N4-(3-Bromophenyl)quinazoline-4,6-diamine
Similarity: 0.82
[ 1038408-36-4 ]
6-Bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Similarity: 0.80
[ 113270-73-8 ]
2-(4-Bromophenyl)-1H-imidazo[4,5-c]pyridine
Similarity: 0.80
[ 1014613-64-9 ]
4-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.80
[ 65147-89-9 ]
6-Bromo-2-phenyl-1H-imidazo[4,5-b]pyridine
Similarity: 0.79
[ 2622-63-1 ]
1-Methyl-2-phenyl-1H-benzo[d]imidazole
Similarity: 0.87
[ 2963-77-1 ]
4-(1H-Benzo[d]imidazol-2-yl)aniline
Similarity: 0.83
[ 13676-49-8 ]
2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine
Similarity: 0.81
[ 1038408-36-4 ]
6-Bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Similarity: 0.80